Mural Oncology plc (NASDAQ: MURA) is -15.53% lower on its value in year-to-date trading and has touched a low of $0.95 and a high of $4.74 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MURA stock was last observed hovering at around $2.69 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $2.72, the stock is 76.19% and -8.04% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.17 million and changing 1.12% at the moment leaves the stock -18.55% off its SMA200. MURA registered -23.81% loss for a year compared to 6-month gain of -26.29%. The firm has a 50-day simple moving average (SMA 50) of $2.9579 and a 200-day simple moving average (SMA200) of $3.339625.
The stock witnessed a -29.35% loss in the last 1 month and extending the period to 3 months gives it a -34.30%, and is 164.08% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 17.31% over the week and 14.75% over the month.
Mural Oncology plc (MURA) has around 116 employees, a market worth around $46.86M and $0.00M in sales. Distance from 52-week low is 186.32% and -42.62% from its 52-week high. The company has generated returns on investments over the last 12 months (-89.89%).
The EPS is expected to grow by 29.52% this year, but quarterly earnings will post 0.00% year-over-year.
Mural Oncology plc (MURA) Top Institutional Holders
98.0 institutions hold shares in Mural Oncology plc (MURA), with institutional investors hold 63.39% of the company’s shares. The shares outstanding are 17.10M, and float is at 15.34M with Short Float at 3.88%. Institutions hold 62.36% of the Float.
The top institutional shareholder in the company is ARMISTICE CAPITAL, LLC with over 1.69 million shares valued at $5.3 million. The investor’s holdings represent 9.9735% of the MURA Shares outstanding. As of 2024-06-30, the second largest holder is SOLAS CAPITAL MANAGEMENT, LLC with 1.27 million shares valued at $3.98 million to account for 7.4979 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 0.84 million shares representing 4.94% and valued at over $2.63 million, while WESTFIELD CAPITAL MANAGEMENT CO LP holds 4.3929 of the shares totaling 0.74 million with a market value of $2.33 million.
Mural Oncology plc (MURA) Insider Activity
#####
Mural Oncology plc disclosed in a document filed with the SEC on Mar 05 ’25 that Keson-Brookes Maikensold a total of 1,469 shares of the company’s common stock. The trade occurred on Mar 05 ’25 and was made at $3.45 per share for $5068.0. Following the transaction, the insider now directly holds 73564.0 shares of the MURA stock.
Still, SEC filings show that on Mar 04 ’25, Keson-Brookes Maiken disposed off 1,262 shares at an average price of $3.36 for $4240.0. The insider now directly holds 75,033 shares of Mural Oncology plc (MURA).
